Bayer Begins To Enroll Patients In Late-stage Trial With Radium-223 Dichloride RTT News The company said that the study evaluates radium-223 in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients with bone predominant metastatic ... |
